These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 11678957

  • 1. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Ji SQ, Chen HR, Xun CQ, Wang HX, Pan SP, Xiao MH.
    Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
    [Abstract] [Full Text] [Related]

  • 2. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

  • 3. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S, Chen H, Wang H, Yan H, Pan S.
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [Abstract] [Full Text] [Related]

  • 4. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
    Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ.
    Biol Blood Marrow Transplant; 2002 Dec; 8(5):261-7. PubMed ID: 12064363
    [Abstract] [Full Text] [Related]

  • 5. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q, Liu H, Liang X, Yang T, Fan Z, Huang F, Ling Y, Liao X, Xuan L, Xu N, Xu X, Ye J, Liu Q.
    J Hematol Oncol; 2017 Jul 04; 10(1):135. PubMed ID: 28676100
    [Abstract] [Full Text] [Related]

  • 6. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, Fruchtman S.
    Bone Marrow Transplant; 1997 Dec 04; 20(12):1033-7. PubMed ID: 9466275
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR, Ji SQ, Wang HX, Yan HM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug 04; 10(4):340-6. PubMed ID: 12513770
    [Abstract] [Full Text] [Related]

  • 8. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
    Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M.
    Biol Blood Marrow Transplant; 2011 Jul 04; 17(7):1018-24. PubMed ID: 21034842
    [Abstract] [Full Text] [Related]

  • 9. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 10. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR, Ji SQ, Yan HM, Wang HX, Liu J, Xue M, Zhu L.
    Zhonghua Er Ke Za Zhi; 2004 Apr 10; 42(4):294-8. PubMed ID: 15157394
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT, Stockschläder M, Schleimer B, Krüger W, Zander AR.
    Transpl Immunol; 1996 Dec 10; 4(4):319-23. PubMed ID: 8972563
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
    Fettah A, Özbek N, Azık F, Tavil B, Özgüner M, Avcı Z, Işık P, Yaralı N, Uçkan D, Tunç B.
    Transfus Apher Sci; 2015 Jun 10; 52(3):332-8. PubMed ID: 25779226
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 10; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 14. [A clinical study of haploidentical and G-CSF primed bone marrow transplantation by using CD25 for aGVHD prophylaxis].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct 10; 10(5):447-51. PubMed ID: 12513746
    [Abstract] [Full Text] [Related]

  • 15. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.
    Kim H, Kang HJ, Lee JW, Park KD, Shin HY, Ahn HS.
    Ann Hematol; 2012 May 10; 91(5):751-758. PubMed ID: 22076065
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.
    Isola L, Scigliano E, Fruchtman S.
    Biol Blood Marrow Transplant; 2000 May 10; 6(4A):428-33. PubMed ID: 10975511
    [Abstract] [Full Text] [Related]

  • 17. [Haploidentical allogeneic bone marrow stem cell transplantation combined with peripheral blood stem cells for therapy of leukemia].
    Yan HM, Xue M, Wang ZD, Zhu L, Liu J, Ding L, Pan SP, Duan LN, Wang HX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct 10; 17(5):1330-4. PubMed ID: 19840477
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE.
    Blood; 1995 Oct 01; 86(7):2842-8. PubMed ID: 7545476
    [Abstract] [Full Text] [Related]

  • 19. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 20. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
    Ji SQ, Chen HR, Wang HX, Yan HM, Zhu L, Liu J, Xue M, Xun CQ.
    Bone Marrow Transplant; 2002 Dec 01; 30(12):861-6. PubMed ID: 12476277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.